- Home
- Equipment
- asia middle east
- genetic mutation
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Genetic Mutation Equipment & Supplies In In Asia Middle East
7 equipment items found
Manufactured by:TIB Molbiol Syntheselabor GmbH based inBerlin, GERMANY
In 2005 we developed our first LightMix Kit detecting bird flu Influenza A H5N1. Since then, we have created many kits testing for different pathogens, hematology markers, genetic mutations and polymorphisms. ...
Manufactured by:Genetic Signatures Ltd. based inNewtown, AUSTRALIA
A full list of the essential respiratory pathogen targets is listed in the table below. User friendly medium to high-throughput systems are available that support Genetic Signatures’ full range of unique 3base™ assays for detecting infectious disease. This patented 3base™ technology has many advantages over conventional 4-base assays, including improved sequence ...
Manufactured by:KORU Medical Systems based inMahwah, NEW JERSEY (USA)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, chronic, life-threatening blood disorder characterized by the complement-mediated destruction (hemolysis) of oxygen-carrying red blood cells. The disease is caused by a genetic mutation in the DNA and causes red blood cells to be missing a critical protein responsible for protecting them. Hemolysis occurs in ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
OncoPeptTUME — A novel in-silico approach to model the tumor microenvironment and predict treatment efficacy and long-term survival benefits for immunotherapy applications. Cancer immunotherapy is now established as a major therapeutic modality. Cancer immunotherapy drugs elicit their anti-tumor immune response in a subset of the treated patients by activating CD8 T-cells and provide ...
Manufactured by:Advanced Molecular Diagnostics based inNottingham, UNITED KINGDOM
More than 1,000 mutations in the CFTR gene have been associated with cystic fibrosis. Most of these mutations in the CFTR gene change the production, structure, or stability of the chloride channel. All of these charevent the channel from functioning properly, which impairs the transport of chloride ions and the movement of water into and out of cells, resulting in cells lining the passageways of ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:EGFR，KRAS，BRAF，PIK3CA，NRAS，HER2，MET，AKT1，KIT，PDGFRA，ALK，ROS1，RET（Detetion of 13 genes） Detection Significance:Guiding the selection of targeted drugs for lung cancer ...
Manufactured by:Elicio Therapeutics based inBoston, MASSACHUSETTS (USA)
Our lymph node-targeted mKRAS cancer vaccine; Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger fight against the most aggressive cancers. Preliminary data have shown that ELI-002 produces a potent mKRAS-specific T-cell response, including both CD4+ and CD8+ ...